An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in their 40s or 50s, according to new findings from ongoing research now ...

An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in their 40s or 50s, according to new findings from ongoing research now ...

A recent study tests a new drug, gantenerumab on people with a genetically inherited form of Alzheimer’s disease. For people with this condition, dementia is almost inevitable. Gantenerumab ...

The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest with recent years witnessing several important controversies. One year earlier, in June 2021 ...

Dementia is a loss of brain function that affects memory, thinking, judgment, behavior, and language. Alzheimer's disease is the most common type of dementia. While there's no cure for dementia, ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study.

He died of Alzheimer’s in 2019, at the age of 66. “That’s old for our family,” Reiswig said. For years, Reiswig resisted finding out whether he carried the mutation, but he did get tested ...

Genes determine our traits, such as our eye colour and height. In some cases, they can also determine whether we develop a disease, like Alzheimer’s, or not. They are “passed on” or inherited from our ...

A new approach to Alzheimer's disease treatment could be on the horizon, inspired by a compound found in common herbs. Carnosic acid is found in rosemary and sage and is known for its antioxidant and ...

Medical experts say it's possible the 95-year-old, who was in declining health and suffering from advanced stages of Alzheimer's disease, did not even realise his wife of more than 30 years was ...